The genetically engineered stem cells have the ability to home to the tumor cells.

Loebinger and Janes determined those cells likely to be resistant to therapies and found that they were just as apt to be destroyed as tumor cells by this novel therapy. In culture, the stem cells caused lung, squamous, breasts and cervical tumor cells to die , even in low stem cell/tumor cell ratios . In mice, the researchers demonstrated that the stem cells could reduce the development of subcutaneous breast tumors by around 80 % . The stem cells could also be injected intravenously as therapy for mice with lung metastases and may eliminate lung metastases in 38 % of mice in comparison to control mice, which still had metastases . It’s the first research to intravenously expose MSCs that have been genetically modified to deliver TRAIL. Drs. Janes and Loebinger chose the breast cancers cells for both versions because in their in vitro experiments, the MSCs ‘demonstrated a particularly strong homing to breast cancer cells.’ ‘Breast cancer tumors certainly are a good style of metastases,’ added Dr.In creating and carrying out the ‘Find the Various other 150’ campaign for PRF, Spectrum collaborated with partner companies in 10 countries through GLOBALHealthPR, the largest independent pr group focused on health communications worldwide. Calling media and doctors with relevant and strategic communications methods culturally, in addition to using online tools like the campaign website . Related StoriesDisclosing genetic risk for CHD outcomes in lower low-density lipoprotein cholesterolNew 3D imaging technology enables researchers look at earliest indicators of heart diseaseSeverely obese children face higher risk of developing heart disease, diabetesThe ‘Discover the Various other 150’ campaign and email address details are discussed in a poster display at the 2010 Centers for Disease Control and Prevention 4th annual National Conference on Health Communication, Marketing and Media .